MedPath

BAYER AG

BAYER AG logo
🇩🇪Germany
Ownership
Public
Established
1863-08-01
Employees
99.7K
Market Cap
$30.1B
Website
http://www.bayer.com
Clinical Trials
Related News

Valette (Combined Oral Contraceptive SH T04769G and SH D00659AF) Low Ovulation Inhibition

Phase 2
Completed
Conditions
Oral Contraceptive
Interventions
Drug: SH T04769G
Drug: Ethinyl estradiol / dienogest (SH D00659 AF)
First Posted Date
2007-05-10
Last Posted Date
2013-01-25
Lead Sponsor
Bayer
Target Recruit Count
60
Registration Number
NCT00471991

Vardenafil Treatment Of Erectile Dysfunction In Depressive And Non-Depressive Men

Completed
Conditions
Erectile Dysfunction
Interventions
Drug: Levitra (Vardenafil, BAY38-9456)
First Posted Date
2007-05-08
Last Posted Date
2014-12-02
Lead Sponsor
Bayer
Target Recruit Count
2471
Registration Number
NCT00470873

Assessment of Compliance With Antihypertensive Telmisartan Therapy

Completed
Conditions
Hypertension
Interventions
Drug: Telmisartan (Kinzal/Pritor, BAY68-9291)
First Posted Date
2007-05-08
Last Posted Date
2012-11-16
Lead Sponsor
Bayer
Target Recruit Count
3400
Registration Number
NCT00470886

The Real-Life Efficacy and Safety of Telmisartan in Patients With Arterial Hypertension

Completed
Conditions
Hypertension
Interventions
Drug: Pritor (Telmisartan , BAY68-9291)
First Posted Date
2007-05-08
Last Posted Date
2010-01-20
Lead Sponsor
Bayer
Target Recruit Count
5448
Registration Number
NCT00471003

A Study of Magnetic Resonance Imaging (MRI) With Gadavist in Children

Phase 1
Completed
Conditions
Magnetic Resonance Imaging
Interventions
Drug: Gadobutrol (Gadavist, Gadovist, BAY86-4875)
First Posted Date
2007-05-03
Last Posted Date
2015-07-22
Lead Sponsor
Bayer
Target Recruit Count
140
Registration Number
NCT00468819

Efficacy and Safety Study for an Oral Contraceptive Containing Folate

Phase 3
Completed
Conditions
Neural Tube Defects
Contraception
Oral Contraceptives (OC)
Interventions
Drug: Drospirenone/Ethinylestradiol/Methyltetrahydrofolate
Drug: Drospirenone/Ethinylestradiol (Yaz)
First Posted Date
2007-05-02
Last Posted Date
2014-04-23
Lead Sponsor
Bayer
Target Recruit Count
385
Registration Number
NCT00468481
Locations
🇺🇸

NorthWest Kinetics, Tacoma, Washington, United States

🇺🇸

Lyndhurst Gynecologic Associates, Winston-Salem, North Carolina, United States

🇺🇸

Orange County Clinical Trials, Anaheim, California, United States

and more 6 locations

Efficacy of Gynodian® Depot in Women With Impaired Well-being

Phase 3
Completed
Conditions
Hormone Replacement Therapy
Interventions
Drug: Gynodian® Depot (BAY86-5032)
Drug: BAY86-4980
First Posted Date
2007-04-20
Last Posted Date
2014-12-30
Lead Sponsor
Bayer
Target Recruit Count
140
Registration Number
NCT00463450

Safety Study of Ethinylestradiol/Drospirenone in Dysmenorrhea

Phase 2
Completed
Conditions
Dysmenorrhea
Interventions
Drug: DRSP 3 mg/EE 30 µg (6 cycles)
Drug: DRSP 3 mg/EE 20 µg (13 cycles)
First Posted Date
2007-04-18
Last Posted Date
2013-01-24
Lead Sponsor
Bayer
Target Recruit Count
420
Registration Number
NCT00461305

Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early Multiple Sclerosis (MS) Treatment With Betaseron

Completed
Conditions
Multiple Sclerosis
Multiple Sclerosis, Relapsing-Remitting
Interventions
Drug: Interferon-1beta (Betaseron, BAY86-5046)
First Posted Date
2007-04-18
Last Posted Date
2011-04-08
Lead Sponsor
Bayer
Target Recruit Count
104
Registration Number
NCT00461396

FDA Phase IV - Commitment - Retinal Function Study

Phase 4
Completed
Conditions
Safety
Interventions
Drug: Placebo
Drug: Sildenafil
Drug: Vardenafil (Levitra, BAY38-9456)
First Posted Date
2007-04-18
Last Posted Date
2015-03-19
Lead Sponsor
Bayer
Target Recruit Count
63
Registration Number
NCT00461565
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy